Core expertise demonstrated across TBMED (testing bed for high-risk devices), SAFE-N-MEDTECH (safety testing for nanotech medical devices, as coordinator), and PICCOLO (photonics endoscope).
FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS
Basque health innovation foundation specializing in medical device safety testing, open innovation testing beds, and nanotechnology-enabled diagnostics validation.
Their core work
BIOEF is the Basque Foundation for Health Innovation and Research, based in Bilbao, Spain. They specialize in bridging the gap between medical technology development and regulatory safety — particularly for high-risk medical devices, in vitro diagnostics, and nanotechnology-enabled health products. They operate testing and validation infrastructure for medtech companies, run pre-commercial procurement processes for integrated care solutions, and support open innovation platforms that connect health technology developers with clinical environments. Their work sits at the intersection of health system needs and industrial medtech innovation.
What they specialise in
Coordinated SAFE-N-MEDTECH focusing on safety testing across the lifecycle of nanoenabled medical technologies and in vitro diagnostics.
Participated in TBMED (Open Innovation Testing Bed), INNO4COV-19 (open innovation platform), and applied Quality by Design methodology.
Carematrix PCP project addresses multimorbidity through pre-commercial procurement of integrated care solutions for aging populations.
Involved in SOTERIA as third party, contributing to personal data protection, anonymization, and biometrics in health contexts.
How they've shifted over time
BIOEF's early H2020 work (2016–2019) centered on clinical diagnostics and medical device development — endoscopy tools (PICCOLO), health data analytics (MIDAS), and safety testing infrastructure for devices. From 2019 onward, their focus broadened significantly: they moved into COVID-19 response platforms, pre-commercial procurement for elderly care, and health data privacy. The shift reveals a trajectory from pure medtech validation toward health system innovation — combining technology assessment with procurement models and data governance.
BIOEF is evolving from a medtech testing organization toward a health system innovation hub that combines device validation, procurement innovation, and data privacy — positioning them for Digital Health and personalized medicine consortia.
How they like to work
BIOEF primarily joins projects as a participant (5 of 7 projects), with one coordination role in SAFE-N-MEDTECH and two third-party contributions. This suggests they are a trusted specialist brought in for specific testing, validation, or regulatory expertise rather than a consortium architect. With 101 unique partners across 21 countries, they maintain a broad European network, indicating they are well-connected and easy to integrate into new consortia.
BIOEF has collaborated with 101 unique partners across 21 countries, forming a wide European network. As a Basque Country health research foundation, they connect Southern European clinical environments with Northern and Central European technology developers.
What sets them apart
BIOEF occupies a rare niche: they combine health innovation research with hands-on testing infrastructure and regulatory pathway knowledge for medical devices. Unlike university labs focused on basic research or companies focused on product development, BIOEF bridges the two — offering open innovation testing beds where developers can validate high-risk devices under realistic conditions. Their public-sector foundation status in the Basque health system gives them direct access to clinical environments and procurement processes that private partners typically cannot reach.
Highlights from their portfolio
- SAFE-N-MEDTECHTheir only coordinator role — focused on safety testing for nanotechnology-enabled medical devices and in vitro diagnostics across their full lifecycle.
- TBMEDLargest single funding (EUR 999,446) — built an open innovation testing bed for high-risk medical device development using Quality by Design methodology.
- Carematrix PCPSignals a strategic shift into pre-commercial procurement for integrated elderly care, combining health system reform with technology deployment.